R&D Women in life sciences: Why female representation still lags... pharmaphorum spoke with Sheila Diamond, director of scientific engagement at Medidata, about being a woman in STEM.
R&D Changing Faces: Pharma and biotech, February 2026 The pharmaceutical and biotech sectors have seen a flurry of executive movement this month.
R&D A complex biological landscape of protein function unlocked ... Promise Bio’s advanced AI-driven system integrates proteomics and multi-omics data, focusing on PTMs to identify unique biomarkers % disease pathways.
R&D How medical supply chains are adapting to global disruptions From the lingering impacts of pandemic-era bottlenecks to geopolitical tensions and extreme weather events, medical supply chains are under pressure.
R&D Treating genetic disease at scale with tRNA, with Michelle W... Michelle Werner, Director of Alltrna, discusses her company’s approach of leveraging transfer RNA (tRNA) to shift the paradigm in genetic medicine.
R&D Closed & Collaborative – January to February 2026 January and February this year weren't a story of a few dominant megadeals, but rather a dense constellation of cross‑disciplinary alliances.
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
